Completed OBSERVATIONAL NCT00390715

Treatment of Acute Myeloblastic Leukemia in Younger Patients

Prospective Study of the Value of the Cytogenetic and of the Monitoring of the Minimal Residual Disease

Sponsor: PETHEMA Foundation

Updated 7 times since 2017 Last updated: Mar 11, 2010 Started: Jan 31, 1999 Primary completion: Dec 31, 2007 Completion: Jan 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Acute Myeloblastic Leukemia, this trial is completed. The trial is conducted by PETHEMA Foundation and has accumulated 7 data snapshots since 1999. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: PHASE4 → None
Jan 2017 — Apr 2018 [monthly]

Completed PHASE4

First recorded

Jan 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

PETHEMA Foundation

Data source: PETHEMA Foundation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

A Coruña, Spain , Alicante, Spain , Barcelona, Spain , Cadiz, Spain , Castelló, Spain , Cáceres, Spain , Córdoba, Spain , Granada, Spain , Huelva, Spain , Jerez de la Frontera, Spain and 20 more locations